Global Wearable Injectors Market Size By Type, By Therapy, By End-User, By Geographic Scope And Forecast -Global Trends and Forecasts(2025 to 2034)
Description
Wearable Injectors Market Size And Forecast
Wearable Injectors Market was valued at USD 6.48 Billion in 2025 and is projected to reach USD 17.13 Billion by 2027, growing at a CAGR of 11.3% from 2020 to 2027.
Global Wearable Injectors Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The Global Wearable Injectors Market is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
Global Wearable Injectors Market Competitive Landscape
The Global Wearable Injectors Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Valeritas, SteadyMed Therapeutics, Tandem Diabetes Care, Amgen, Medtronic, Insulet Corporation, United Therapeutic Corporation, Enable Injections, Ypsomed, Becton, Dickinson and Company.
Wearable Injectors Market was valued at USD 6.48 Billion in 2025 and is projected to reach USD 17.13 Billion by 2027, growing at a CAGR of 11.3% from 2020 to 2027.
Global Wearable Injectors Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The Global Wearable Injectors Market is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
Global Wearable Injectors Market Competitive Landscape
The Global Wearable Injectors Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Valeritas, SteadyMed Therapeutics, Tandem Diabetes Care, Amgen, Medtronic, Insulet Corporation, United Therapeutic Corporation, Enable Injections, Ypsomed, Becton, Dickinson and Company.
Table of Contents
202 Pages
- 1 Introduction Of Global Wearable Injectors Market
- 1.1 Overview Of The Market
- 1.2 Scope Of Report
- 1.3 Assumptions
- 2 Executive Summary
- 3 Research Methodology Of Factview Research
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List Of Data Sources
- 4 Global Wearable Injectors Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Wearable Injectors Market, By Type
- 5.1 Overview
- 5.2 On-body Injectors
- 5.3 Off-body Injectors
- 6 Global Wearable Injectors Market, By Therapy
- 6.1 Overview
- 6.2 Immuno-oncology
- 6.3 Diabetes
- 6.4 Cardiovascular Diseases
- 6.5 Other
- 7 Global Wearable Injectors Market, By End-user
- 7.1 Overview
- 7.2 Hospitals
- 7.3 Clinics
- 7.4 Home Care Settings
- 7.5 Other
- 8 Global Wearable Injectors Market, By Geography
- 8.1 Overview
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest Of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest Of Asia Pacific
- 8.5 Rest Of The World
- 8.5.1 Latin America
- 8.5.2 Middle East
- 9 Global Wearable Injectors Market Competitive Landscape
- 9.1 Overview
- 9.2 Company Market Ranking
- 9.3 Key Development Strategies
- 10 Company Profiles
- 10.1 Valeritas
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
- 10.2 Steadymed Therapeutics
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
- 10.3 Sensile Medicals
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
- 10.4 Tandem Diabetes Care
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
- 10.5 Amgen
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
- 10.6 Medtronic
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
- 10.7 Insulet Corporation
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
- 10.8 United Therapeutic Corporation
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
- 10.9 Enable Injections
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
- 10.10 Becton, Dickinson And Company
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
- 11 Appendix
- 11.1 Related Research
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

